BioCentury | Nov 22, 1999
Company News

Proteus, Thallia Pharmaceuticals SA deal

...Proteus acquired a collection of microalgae from Thallia to add to its microbial biodiversity libraries for...
...to add to its microbial biodiversity libraries for drug screening. Proteus S.A. , Nimes, France Thallia...
BioCentury | Oct 18, 1999
Finance

Thallia throws in the towel

...Axis Genetics plc , the plant-based vaccine company in the U.K. (see BioCentury, Sept. 13). Thallia...
...a question of trying to raise money at the wrong time," he told BioCentury. Initially, Thallia...
...March 29). Ironically, Gilbert said, on the day he decided to wrap up the company, Thallia...
BioCentury | May 3, 1999
Finance

Oh, Canada!

...in a private placement from existing shareholders Atlas, 3i and GIMV plus several European institutions. Thallia...
BioCentury | Mar 29, 1999
Company News

Thallia Pharmaceuticals SA, Rowett Research Institute deal

...Thallia will have exclusive worldwide rights to market the nutraceuticals as dietary supplements and/or pharmaceuticals. Thallia...
BioCentury | Mar 29, 1999
Finance

Pummeled

...a market cap of £107 million ($174 million), is now trading at cash. Market hopeful Thallia...
BioCentury | Oct 19, 1998
Finance

Deja vu all over again

...percent from $36.06 to close Friday at $42, as news of the company's deal with Thallia...
BioCentury | Oct 12, 1998
Company News

Thallia board of directors update

Thallia Pharmaceuticals S.A., Ecully, France Business: Enabling technology Appointed: Hugo Van Heuverswyn, CEO of Innogenetics N.V. WIR Staff...
BioCentury | Oct 12, 1998
Company News

Thallia scientific advisory board update

Thallia Pharmaceuticals S.A., Ecully, France Business: Enabling technology Appointed: Andre Van de Voorde, CSO of Innogenetics N.V. WIR Staff...
BioCentury | Oct 5, 1998
Company News

Biosearch Italia SA, Thallia Pharmaceuticals SA deal

...The companies will discover and develop anti-infective compounds. Thallia will provide its microalgae collection, while Biosearch...
...molecule generated by the collaboration will be jointly owned. Biosearch Italia SA , Milan, Italy Thallia...
BioCentury | Feb 23, 1998
Company News

Thallia, Glaxo Wellcome deal

...provide Glaxo with microalgae extracts for screening against unspecified Glaxo targets to identify new compounds. Thallia Pharmaceuticals S.A....
Items per page:
1 - 10 of 17
BioCentury | Nov 22, 1999
Company News

Proteus, Thallia Pharmaceuticals SA deal

...Proteus acquired a collection of microalgae from Thallia to add to its microbial biodiversity libraries for...
...to add to its microbial biodiversity libraries for drug screening. Proteus S.A. , Nimes, France Thallia...
BioCentury | Oct 18, 1999
Finance

Thallia throws in the towel

...Axis Genetics plc , the plant-based vaccine company in the U.K. (see BioCentury, Sept. 13). Thallia...
...a question of trying to raise money at the wrong time," he told BioCentury. Initially, Thallia...
...March 29). Ironically, Gilbert said, on the day he decided to wrap up the company, Thallia...
BioCentury | May 3, 1999
Finance

Oh, Canada!

...in a private placement from existing shareholders Atlas, 3i and GIMV plus several European institutions. Thallia...
BioCentury | Mar 29, 1999
Company News

Thallia Pharmaceuticals SA, Rowett Research Institute deal

...Thallia will have exclusive worldwide rights to market the nutraceuticals as dietary supplements and/or pharmaceuticals. Thallia...
BioCentury | Mar 29, 1999
Finance

Pummeled

...a market cap of £107 million ($174 million), is now trading at cash. Market hopeful Thallia...
BioCentury | Oct 19, 1998
Finance

Deja vu all over again

...percent from $36.06 to close Friday at $42, as news of the company's deal with Thallia...
BioCentury | Oct 12, 1998
Company News

Thallia board of directors update

Thallia Pharmaceuticals S.A., Ecully, France Business: Enabling technology Appointed: Hugo Van Heuverswyn, CEO of Innogenetics N.V. WIR Staff...
BioCentury | Oct 12, 1998
Company News

Thallia scientific advisory board update

Thallia Pharmaceuticals S.A., Ecully, France Business: Enabling technology Appointed: Andre Van de Voorde, CSO of Innogenetics N.V. WIR Staff...
BioCentury | Oct 5, 1998
Company News

Biosearch Italia SA, Thallia Pharmaceuticals SA deal

...The companies will discover and develop anti-infective compounds. Thallia will provide its microalgae collection, while Biosearch...
...molecule generated by the collaboration will be jointly owned. Biosearch Italia SA , Milan, Italy Thallia...
BioCentury | Feb 23, 1998
Company News

Thallia, Glaxo Wellcome deal

...provide Glaxo with microalgae extracts for screening against unspecified Glaxo targets to identify new compounds. Thallia Pharmaceuticals S.A....
Items per page:
1 - 10 of 17